Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析

◆英語タイトル:Jiangsu Hengrui Medicine Co Ltd (600276) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4826
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Jiangsu Hengrui Medicine Co Ltd (600276) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes antineoplastic products, anti-tumor drugs, surgical drugs and contrast agents. The company offers products in central nervous system (CNS), musculoskeletal, metabolic, hematologic, infection, respiratory, cardiovascular, dermatology, gastrointestinal, cancer and other areas. Jiangsu Hengrui has manufacturing and R&D facilities in Shanghai, Chengdu, Suzhou and Lianyungang, China. The company offers its products through sales and distribution network spread across China. Jiangsu Hengrui is headquartered in Lianyungang, Jiangsu Province, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Jiangsu Hengrui Medicine Co Ltd – Key Facts 5
Jiangsu Hengrui Medicine Co Ltd – Key Employees 6
Jiangsu Hengrui Medicine Co Ltd – Major Products and Services 7
Jiangsu Hengrui Medicine Co Ltd – History 10
Jiangsu Hengrui Medicine Co Ltd – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 12
Section 2 – Company Analysis 14
Company Overview 14
Jiangsu Hengrui Medicine Co Ltd – Business Description 15
Business Segment: Other Business 15
Performance 15
Business Segment: Pharmaceutical Manufacturing 15
Performance 15
Geographical Segment: Domestic 15
Performance 15
Geographical Segment: Foreign 16
Performance 16
R&D Overview 16
Jiangsu Hengrui Medicine Co Ltd – SWOT Analysis 17
SWOT Analysis – Overview 17
Jiangsu Hengrui Medicine Co Ltd – Strengths 17
Jiangsu Hengrui Medicine Co Ltd – Weaknesses 18
Jiangsu Hengrui Medicine Co Ltd – Opportunities 19
Jiangsu Hengrui Medicine Co Ltd – Threats 20
Jiangsu Hengrui Medicine Co Ltd – Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios – Capital Market Ratios 22
Financial Ratios – Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios – Interim Ratios 27
Financial Ratios – Ratio Charts 28
Section 4 – Company’s Lifesciences Financial Deals and Alliances 29
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary 31
Section 5 – Appendix 32
Methodology 32
Ratio Definitions 32
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Jiangsu Hengrui Medicine Co Ltd, Key Facts 5
Jiangsu Hengrui Medicine Co Ltd, Key Employees 6
Jiangsu Hengrui Medicine Co Ltd, Major Products and Services 7
Jiangsu Hengrui Medicine Co Ltd, History 10
Jiangsu Hengrui Medicine Co Ltd, Subsidiaries 12
Jiangsu Hengrui Medicine Co Ltd, Joint Venture 12
Jiangsu Hengrui Medicine Co Ltd, Key Competitors 21
Jiangsu Hengrui Medicine Co Ltd, Ratios based on current share price 22
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios 23
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios (Cont...1) 24
Jiangsu Hengrui Medicine Co Ltd, Annual Ratios (Cont...2) 25
Jiangsu Hengrui Medicine Co Ltd, Interim Ratios 27
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30
Jiangsu Hengrui Medicine Co Ltd, Recent Deals Summary 31
Currency Codes 32
Capital Market Ratios 32
Equity Ratios 33
Profitability Ratios 33
Cost Ratios 34
Liquidity Ratios 34
Leverage Ratios 35
Efficiency Ratios 35

List of Figures
Jiangsu Hengrui Medicine Co Ltd, Performance Chart (2013 - 2017) 26
Jiangsu Hengrui Medicine Co Ltd, Ratio Charts 28
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29
Jiangsu Hengrui Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30

★海外企業調査レポート[Jiangsu Hengrui Medicine Co Ltd (600276):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PhoenixBio Co Ltd (6190):企業の財務・戦略的SWOT分析
    Summary PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services including dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blo …
  • China Bohai Bank Co., Ltd:企業の戦略・SWOT・財務情報
    China Bohai Bank Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary China Bohai Bank Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務分析
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Synergy:企業の戦略・SWOT・財務情報
    Synergy - Strategy, SWOT and Corporate Finance Report Summary Synergy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Tactile Systems Technology Inc (TCMD):製品パイプライン分析
    Summary Tactile Systems Technology Inc (Tactile Medical) is a medical technology company that develops, manufactures and distributes medical devices for the treatment of chronic vascular diseases in a home setting. The company’s products are based on a unique, scalable platform. It offers products f …
  • Mersana Therapeutics Inc (MRSN):製薬・医療:M&Aディール及び事業提携情報
    Summary Mersana Therapeutics Inc (Mersana) formerly Nanopharma Corp is a clinical-stage biopharmaceutical company that offers antibody drug conjugate to improve patients’ lives. The company offers pipeline product XMT-1522, for HER-2 targeted therapies based on its Dolaflexin platform. It utilizes F …
  • Canadian Natural Resources Ltd (CNQ):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing and sale of crude oil, natural gas and natural gas liquids (NGLs). Canadian Natural’s products include light …
  • Industrias Metalurgicas Pescarmona SA:企業の戦略的SWOT分析
    Industrias Metalurgicas Pescarmona SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Cimarex Energy Co (XEC):企業の財務・戦略的SWOT分析
    Cimarex Energy Co (XEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ingles Markets Inc:企業の戦略・SWOT・財務情報
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • VeriFone Systems Inc:企業のM&A・事業提携・投資動向
    VeriFone Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's VeriFone Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Viveve Medical Inc (VIVE):医療機器:M&Aディール及び事業提携情報
    Summary Viveve Medical Inc (Viveve Medical), formerly PLC Systems Inc, is a medical device company that develops women’s health and wellness treatment solutions. The company offers non-prescription device to treat incontinence pelvic floor muscles, overactive detrusor muscle, urinary incontinence, O …
  • Cameco Corporation:企業の戦略・SWOT・財務情報
    Cameco Corporation - Strategy, SWOT and Corporate Finance Report Summary Cameco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pfizer Inc (PFE)-製薬・医療分野:企業M&A・提携分析
    Summary Pfizer Inc (Pfizer) is a biopharmaceutical company, which discovers, develops, manufactures and markets healthcare products. It provides medicines, vaccines and consumer healthcare products. The company provides products to treat various conditions including infection, cancer, inflammation, …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a pharmaceutical company which manufactures and markets active pharmaceutical ingredients, generics and formulations for various therapeutic areas. The company’s active pharmaceutical ingredients include anti-hypertensive, anti-malarial, diuretic and anthelmin …
  • Origin Energy Limited:企業の戦略・SWOT・財務情報
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Corning Incorporated (GLW)-エネルギー分野:企業M&A・提携分析
    Summary Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for tele …
  • Linedata Services SA (LIN):企業の財務・戦略的SWOT分析
    Linedata Services SA (LIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆